protein tyrosine phosphatase 1B inhibitors (Qiqihar University/Gyeongsang National University/Cornell University)

N/A

Report date: 2025/01/26 16:50:32
NME

Base Information

Drug Nameprotein tyrosine phosphatase 1B inhibitors (Qiqihar University/Gyeongsang National University/Cornell University)
Drug Alias Name6,8-diprenylorobol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQiqihar University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A